Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

Burkhard Jansen, Volker Wacheck, Elisabeth Heere‐Ress et al. · The Lancet · 2000 · 481 citations

Medicine, Cancer Biology, Oncology +14

Analysis of Oligonucleotides by HPLC−Electrospray Ionization Mass Spectrometry

Alex Apffel, John A. Chakel, Steven M. Fischer et al. · Analytical Chemistry · 1997 · 398 citations

Pharmacy, Biochemistry, Chemistry +16

High-Performance Liquid Chromatography−Electrospray Ionization Mass Spectrometry of Single- and Double-Stranded Nucleic Acids Using Monolithic Capillary Columns

Andreas Premstaller, Herbert Oberacher, Christian G. Huber · Analytical Chemistry · 2000 · 284 citations

Pharmacy, Molecular Biology, Analytical Chemistry +16

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

Guido Marcucci, John C. Byrd, Guowei Dai et al. · Blood · 2002 · 220 citations · Full text

Medicine, Oncology, Pharmacology +14

Interpretation of Oligonucleotide Mass Spectra for Determination of Sequence Using Electrospray Ionization and Tandem Mass Spectrometry

Jinsong Ni, Steven C. Pomerantz, Jef Rozenski et al. · Analytical Chemistry · 1996 · 184 citations

Life Sciences, Biochemistry, Molecular Biology +17